常用名 | JNJ-55308942 | CAS号 | 2166558-11-6 |
---|---|---|---|
价格 | 纯度 | 98.0% | |
备货期 | 10天 | 库存 | 现货 |
产品详情(用途,包装等)
用途: JNJ-55308942 is a novel highly potent P2X7 antagonist with Ki of 1.0 and 6.5 nM for rat and human hP2X7, demonstrates significant activity against a panel of related P2X receptors (P2X1, P2X2, P2X3, P2X2/3, and P2X4; also shows insignificant inhibition of nine CYP isoforms (IC50>15 uM); exhibits excellent P2X7 receptor occupancy in the hippocampus of rats with low ED50 of 0.07 mg/kg and unbound plasma EC50 of 12 ng/mL, suppresses brain IL-1β release in vivo in freely moving rats challenged with the P2X7 agonist Bz-ATP; possesses good tolerability margins in preclinical species, as well as an acceptable cardiovascular safety profile in vivo. Epilepsy Phase 1 Clinical 物理化学性质: CAS号:2166558-11-6 常用中文名:JNJ-55308942 常用英文名:JNJ-55308942 分子式:C17H12F5N7O 分子量:425.323 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A 储存条件:-20°C |